- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
C
CPRX
Catalyst Pharmaceuticals Inc
24.15
-0.13-0.54%Opening12:32 04/30 EDT
OPEN/PREV CLOSE24.28/24.28
TODAY RANGE24.01-24.61
VOL300.53K
MARKET CAP2.95B
52 WEEK RANGE14.47-26.16
AVG VOL (3M)1.25M
% TURNOVER0.25%
TURNOVER--
P/E (TTM)18.41
% RANGE2.47%
EPS(TTM)1.312
P/E(FORWARD)17.50
P/B4.012
BVPS6.02
DIVIDEND--
P/S5.94
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.76B
SHARES OUTSTANDING121.96M
NEXT EARNINGS--
FREE FLOAT114.30M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·19h ago
Catalyst Pharmaceuticals Inc. Stock Rallies 2.8%, Outperforms Market
TipRanks·04/21 13:37
Catalyst Pharmaceuticals price target raised to $34 from $33 at BofA
TipRanks·04/17 11:16
Citi Remains a Buy on Catalyst Pharma (CPRX)
Dow Jones·04/16 20:34
Catalyst Pharmaceuticals Inc. Stock Falls 4.5%, Underperforms Competitors
NASDAQ·04/11 15:30
Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?
TipRanks·04/08 12:26
Catalyst Pharmaceuticals announces Health Canada’s acceptance of AGAMREE NDS
TipRanks·04/08 12:06
Catalyst Pharmaceuticals submits NDS to Health Canada for Agamree
Dow Jones·04/07 20:34
Catalyst Pharmaceuticals Inc. Stock Slides 5.5%, Underperforms Competitors
TipRanks·03/27 16:25
Biotech Alert: Searches spiking for these stocks today
NASDAQ·03/25 15:08
Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?
Dow Jones·03/24 20:33
Catalyst Pharmaceuticals Inc. Stock Advances 6.2%, Outperforms Competitors
Benzinga·03/23 21:28
Celsius, Lucid And Signet Are Among Top 10 Mid-Cap Gainers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?
Same Industry
Name/Symbol
Change%
Price